PURPOSE: To determine the impact of skin pretreatment with microneedles (MNs) on ALA- and MAL-induced protoporphyrin IX (PpIX) production, as well as MN impact on pain sensations during light exposure and erythema after PDT. METHODS: The skin of 14 healthy volunteers was preteated with MNs. Equal amounts of creams containing 2%, 8% and 16% (w/w) ALA and MAL were applied on 1 cm(2) areas for 4 h. Additionally, 16% ALA and MAL creams were applied for 24 h. Afterwards, PpIX fluorescence spectra were measured. Sixteen percent ALA and MAL spots were exposed to red light (632 nm, 77 mW/cm(2)). Time for pain to occur was measured in seconds, and erythemal response was monitored up to 6 h after the end of the light exposure. RESULTS: Use of MNs increased the PpIX fluorescence after 4 h incubation time with 2% and 8% ALA or MAL, but not with 16% ALA or MAL. Pretreatment with MNs did not increase the pain sensations during light exposure, nor did it influence erythema occurrence. CONCLUSIONS: MNs are a promising tool for improving the efficiency of topical PDT by improving the cutaneous delivery of ALA and MAL, without increase in side effects.
PURPOSE: To determine the impact of skin pretreatment with microneedles (MNs) on ALA- and MAL-induced protoporphyrin IX (PpIX) production, as well as MN impact on pain sensations during light exposure and erythema after PDT. METHODS: The skin of 14 healthy volunteers was preteated with MNs. Equal amounts of creams containing 2%, 8% and 16% (w/w) ALA and MAL were applied on 1 cm(2) areas for 4 h. Additionally, 16% ALA and MAL creams were applied for 24 h. Afterwards, PpIX fluorescence spectra were measured. Sixteen percent ALA and MAL spots were exposed to red light (632 nm, 77 mW/cm(2)). Time for pain to occur was measured in seconds, and erythemal response was monitored up to 6 h after the end of the light exposure. RESULTS: Use of MNs increased the PpIX fluorescence after 4 h incubation time with 2% and 8% ALA or MAL, but not with 16% ALA or MAL. Pretreatment with MNs did not increase the pain sensations during light exposure, nor did it influence erythema occurrence. CONCLUSIONS:MNs are a promising tool for improving the efficiency of topical PDT by improving the cutaneous delivery of ALA and MAL, without increase in side effects.
Authors: Ryan F Donnelly; Desmond I J Morrow; Paul A McCarron; A David Woolfson; Anthony Morrissey; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Helen O McCarthy; Johan Moan Journal: J Control Release Date: 2008-05-10 Impact factor: 9.776
Authors: Zhimin Luo; Wujin Sun; Jun Fang; KangJu Lee; Song Li; Zhen Gu; Mehmet R Dokmeci; Ali Khademhosseini Journal: Adv Healthc Mater Date: 2018-12-19 Impact factor: 9.933
Authors: Gayathri Krishnan; Michael S Roberts; Jeffrey Grice; Yuri G Anissimov; Hamid R Moghimi; Heather A E Benson Journal: Drug Deliv Transl Res Date: 2014-06 Impact factor: 4.617
Authors: Yasmine A Gomaa; Labiba K El-Khordagui; Martin J Garland; Ryan F Donnelly; Fiona McInnes; Victor M Meidan Journal: J Pharm Pharmacol Date: 2012-07-09 Impact factor: 3.765
Authors: Ryan F Donnelly; Desmond I J Morrow; Maelíosa T C McCrudden; Ahlam Zaid Alkilani; Eva M Vicente-Pérez; Conor O'Mahony; Patricia González-Vázquez; Paul A McCarron; A David Woolfson Journal: Photochem Photobiol Date: 2013-12-05 Impact factor: 3.421